Bivalirudin-associated intracoronary thrombosis during γ- brachytherapy and its experimental validation in acute swine model

Catheterization and Cardiovascular Interventions

Volumn 62, Issue 2, 2004, Pages 209-213

  Kuchulakanti, Pramod K ^a   Satler, Lowell F ^a   Rha, Seung Woon ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

radiation; Bivalirudin; Intracoronary thrombosis

Indexed keywords

EPTIFIBATIDE; HIRULOG;

ADULT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BETA RADIATION; BOLUS INJECTION; BRACHYTHERAPY; CASE REPORT; CONTINUOUS INFUSION; CORONARY BRACHYTHERAPY; FEMALE; GAMMA RADIATION; HUMAN; IN STENT RESTENOSIS; INTRACORONARY THROMBOSIS; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; SWINE; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTICOAGULANTS; ANTITHROMBINS; BRACHYTHERAPY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY THROMBOSIS; FEMALE; GAMMA RAYS; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SWINE;

EID: 2942709698     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.20056     Document Type: Article

References (8)

1. Bittl JA, Chaitman BR, Feit F, Kimball W, Topol EJ, on behalf of the Bivalirudin Angioplasty Study investigators. Bivalirudin versus heparin during coronary angioplasty for unstable or post infarction angina: final report reanalysis of the Bivalirudin Angioplasty Study. Am Heart J 2001;142:952-959.
2. Yousuf S, for the Direct Thrombin Inhibitor Trialists' Collaborative Group. Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data. Lancet 2002;359:294-302.
3. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Kereiakes DJ, Rutsch W, Wilcox RG, De Feyter PJ, Vahanian A, Topol EJ, for the REPLACE-2 investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863.
4. Waksman R. Vascular brachytherapy: applications in the era of drug eluting stents. Rev Cardiovasc Med 2002;3:S23-S30.
5. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Chiu Wong S, Fish D, Ellis S, Holmes DR, Kerieakes D, Kuntz RE. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344: 250-256.
6. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, Satler LF, Mehran R, Serruys PW, Lansky AJ, Fitzgerald P, Bhargava B, Kent KM, Pichard AD, Leon MB. Intracoronary γ-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171.
7. Sharma S, Bhambi B, Nyitray W, Desai K, Davis DL, Sharma G, Shukla P, File C, Ishimori T. Bivalirudin (angiomax) use during intracoronary brachytherapy may predispose to acute closure. J Cardiovasc Pharmacol Ther 2003;8:9-15.
8. Sciulli TM, Mauro VF. Pharmacology and clinical use of bivalirudin. Ann Pharmacother 2002;36:1028-1041.